Exclusive: Infectious disease doctors consider 'mini-ACIP' if RFK erodes CDC vaccine panel

Max Bayer

Pharma Reporter

Infectious disease professionals, bracing for an overhaul of the CDC’s vaccine advisory group, are in discussions to stand up a parallel committee of experts outside …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: Infectious disease doctors consider 'mini-ACIP' if RFK erodes CDC vaccine panel

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

At least six drugmakers say they will participate in round two of IRA negotiations

Lilly joins molecular glue field with Magnet deal worth up to $1.25B

How AI can address ongoing challenges in the life sciences industry

Ex­clu­sive: In­fec­tious dis­ease doc­tors con­sid­er 'mi­ni-ACIP' if RFK erodes CDC vac­cine pan­el

Pharma Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Exclusive: Infectious disease doctors consider 'mini-ACIP' if RFK erodes CDC vaccine panel